Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl cysteine for post-reperfusion injury in CTEPH
NCT04081012Unknown
- Sponsor
- Instituto Nacional de Cardiología Ignacio Chávez
- Start
- May 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Lung Ischemia Reperfusion Injury (LIRI) comparing N-acetyl Cysteine with Placebo (2 arms). Primary endpoint: Presence of Post-reperfusion pulmonary injury at 72 hours. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
Lung Ischemia Reperfusion Injury (LIRI)
Beyond the preview
Go deeper on NCT04081012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04081012.